Document is current
Any future updates will be listed below
-
Authors
Geleta, Dessalegn https://orcid.org/0000-0002-8725-7049
Brhane, Bokretsion G.
Abera, Adugna
Belachew, Mahlet
Sime, Heven
Gebreegziaxher, Atsbeha
Getu, Melak
Ali, Abraham
Tesfay, Neamin
Habtetsion, Medhanye
Kokobe, Belayneh
Kebede, Mandefro
Worku, Zemene
Tasew, Geremew
Tadesse, Gemechu
Tollera, Getachew
Fola, Abebe A.
Bailey, Jeffrey A.
Juliano, Jonathan J.
Parr, Jonathan B.
Abte, Melkamu
Assefa, Ashenafi
- License Information
-
More Information
Article History
Received: 11 March 2026
Accepted: 27 July 2026
First Online: 31 July 2026
Declarations
Ethics approval and consent to participate: This study obtained approval from the scientific and review committee of the EPHI. Permission was obtained from EPHI to use the national EPI-week-based malaria data. Data were collected from consented patients as per the Helsinki principles.
Competing interests: Authors declare that there is no competing interest. JBP reports non-financial support from Abbott Laboratories and past research support from Gilead Sciences and consulting for Zymeron Corp, outside the scope of this work,
